Ledger.Open graph →
SEC Form D · filed May 23, 2022

Neurexis Therapeutics, Inc

Offering
$200K
Sold
$55K
Exemption
Rule 506(b)
Industry
Other
Location
AURORA, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

David Weiss, M.D · Cooper City, FLDirectorMichael C. Artinger · Fayetteville, ARExec · DirectorK. U. Bayer · Aurora, CODirectorMichael C. Artinger · Fayetteville, ARExec · DirectorK. U. Bayer · Aurora, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗